How India Polices Drug Crime
India's primary drug law is the Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS Act) — a comprehensive statute criminalising production, manufacture, possession, sale, purchase, transport, and consumption of narcotic drugs and psychotropic substances.
The NDPS Act is notable for: mandatory minimum sentences (no judicial discretion below the minimum for commercial quantities); extremely stringent bail provisions that reverse the normal presumption of innocence (Section 37 NDPS: bail requires the court to be satisfied that there are "reasonable grounds for believing that the accused is not guilty" — an almost impossible standard before trial); and sentence structures ranging from small quantity penalties to life imprisonment for large commercial quantities.
![]() |
| Representational Image: How India Polices Drug Crime |
India occupies a strategically exposed geographic position in global drug trade: landlocked by the Golden Triangle (Myanmar, Thailand, Laos — world's second-largest opium producer) to the east and the Golden Crescent (Afghanistan, Pakistan, Iran — world's largest) to the northwest. Drug seizures along India's borders reflect transit flows; India's domestic drug market — historically cannabis (ganja, charas) and opium-based products — now includes significant methamphetamine consumption (Punjab) and heroin.
Punjab's
drug crisis is the most documented domestic drug problem: the state's extensive
border with Pakistan, large diaspora sending remittances that reduce economic
barriers to consumption, and documented drug trafficking networks with Pakistan
connections have produced a documented methamphetamine ("chitta")
epidemic with severe social consequences.
What You Need to Know
- NDPS
Act (1985): covers narcotic drugs, psychotropic substances, and controlled
substances; three quantity categories: small quantity (personal use
scale), more than small quantity (intermediate), commercial quantity
(large-scale trafficking); penalties range from 1 year (small quantity
possession) to life imprisonment (commercial quantity trafficking);
mandatory minimums for commercial quantities; NCB, state police narcotics
cells, revenue intelligence, and customs all have NDPS enforcement
jurisdiction.
- Bail
under NDPS Section 37: bail not to be granted unless court is satisfied
there are "reasonable grounds for believing the accused is not guilty
of such offence and that he is not likely to commit any offence while on
bail"; the dual condition (not guilty + unlikely to reoffend) is
extremely difficult to satisfy pre-trial; produces mass pretrial detention
for commercial NDPS cases.
- Punjab
drug crisis: methamphetamine ("chitta") epidemic documented
since approximately 2016; linked to Pakistan-origin trafficking across the
border; state government commissioned multiple reports; de-addiction
programmes (OAT — Opioid Assisted Treatment) introduced; 2022 Bhagwant
Mann AAP government continued OAT programme expansion; 2024 Drug
de-addiction helpline: 104 (24/7, toll-free).
- Narcotics
Control Bureau (NCB): central agency under MHA; coordinates national narco
enforcement; intelligence-based operations; major seizures of heroin,
opium, cannabis, MDMA, and new psychoactive substances; operates 5
regional offices and zonal offices; coordinates with INTERPOL, DEA, and
bilateral drug enforcement partners.
- "Dark
net" and synthetic drug market: NCRB data documents emergence of
synthetic drugs (MDMA, LSD, ketamine) in urban markets; darknet
procurement of controlled substances documented in Delhi, Mumbai,
Bengaluru; enforcement of online drug markets requires specialist cyber
and financial investigation skills that most state police forces lack.
How It Works in Practice
1. The quantity-based prosecution model: NDPS Act
prosecutions hinge on the quantity seized: small quantity (e.g., 5g heroin) —
up to 1 year; more than small but less than commercial — up to 10 years;
commercial quantity (e.g., 250g heroin) — 10 years to life. The quantity
categorisation creates enforcement gaming: drug network organisers typically
avoid possessing commercial quantities directly, structuring their operations
to keep street-level distributors (who bear arrest risk) below commercial
quantity thresholds; the kingpin retains distance from prosecution while
street-level distributors face severe minimum sentences.
2. Punjab's integrated response model: Punjab's most
recent drug response combines: enhanced border enforcement (BSF, Customs, Army
intelligence on Pakistan border routes); NCB task force operations; state
police narcotics special wings; a district-level drug de-addiction centre
network; and OAT (buprenorphine maintenance therapy) prescribing. The
multi-pronged approach recognises that supply-side enforcement alone is
insufficient when demand-side vulnerability (unemployment, social
marginalisation, readily available supply) persists.
3. The NDPS Act's human rights dimension: Civil
liberties organisations have consistently documented that NDPS Act's Section 37
bail restrictions produce prolonged pretrial detention for drug offences that
disproportionately affect poor people caught with small quantities; wealthy
users and organisers with legal resources obtain bail more readily than poor
transporters and street distributors. The Act's mandatory minimum sentences
limit judicial discretion even where circumstances (first offence, personal use
motivation, poverty) would otherwise support leniency.
4. Narco-politics in Punjab: Punjab's drug crisis has
a political dimension: multiple investigations and media reports have alleged
police protection of drug trafficking networks; the FIR against former Punjab
CM's son (Bikram Singh Majithia, NDPS case, filed 2022) illustrates that
political figures have been implicated in drug networks; the NIA and NCB have
investigated cases with political connections; the intersection of organised
crime and politics is more acute in Punjab's drug trafficking than in most
other Indian criminal contexts.
5. India as a pharma-drug diversion risk: India's
pharmaceutical manufacturing capacity (world's third-largest) creates a
specific drug control risk: controlled substances produced legally for
pharmaceutical export can be diverted into illegal channels; painkiller
diversion (tramadol, codeine) and precursor chemical diversion (pseudoephedrine
for methamphetamine synthesis) are documented enforcement challenges; the Drug
Regulatory Authority (CDSCO) and NCB jointly address pharmaceutical diversion.
What People Often Misunderstand
- NDPS
bail restrictions apply even to first-time small-quantity users in some
states: The Section 37 standard is triggered by the quantity seized,
not the history of the accused; a first-time user caught with commercial
quantities faces the same bail restriction as a repeat trafficker; this is
a documented source of disproportionate pretrial detention.
- Cannabis
regulation in India is complicated: Ganja (leaf/flower) and charas
(resin) are Schedule I controlled substances under NDPS; bhang (prepared
from cannabis leaves) has a different status — the NDPS Act Schedule only
covers cannabis resin and flowering tops, not seeds and leaves in certain
preparations, which is why bhang shops are legal in some states; this
legal complexity produces inconsistent enforcement.
- India's
Golden Triangle exposure is primarily for transit, not domestic
production: India produces some cannabis (Malana Cream from Himachal
Pradesh is internationally known) but is primarily a transit country for
heroin from Myanmar and Afghanistan; the transit exposure creates domestic
market leakage — some fraction of transit product enters Indian domestic
consumption — rather than India being a primary production country.
- Drug
mule interceptions at airports are documented but not the primary
trafficking route: Media coverage of airport drug mule arrests (often
African or Southeast Asian nationals carrying swallowed or body-concealed
packages) creates disproportionate attention to this high-visibility but
relatively small-quantity trafficking mode; the primary trafficking
volumes move overland through the Punjab border, northeastern borders, and
coastal routes.
- De-addiction
treatment is more cost-effective than enforcement for consumption-end drug
problems: Public health evidence consistently demonstrates that harm
reduction (OAT, clean needle programmes) and treatment (rehabilitation,
counselling) produce better outcomes per rupee than arrest-and-prosecution
for drug users; India's policy mix has historically over-weighted
enforcement; Punjab's OAT expansion represents a policy shift toward the
evidence base.
What Changes Over Time
The NDPS Act is under judicial pressure for its bail provisions (multiple Supreme Court cases arguing proportionality; the V. Senthil Balaji judgment's application to NDPS bail is contested); a legislative amendment reducing bail restriction for small-quantity possession would be the most significant NDPS reform possible.
The Indian government's 2023–24 drug
demand reduction policy — launching 294 district-level de-addiction centres —
represents the supply/demand balance shift in official policy.
Sources and Further Reading
- Drishti IAS — NCRB 2024: https://www.drishtiias.com/daily-updates/daily-news-analysis/ncrbs-crime-in-india-2024-report
- Bar
and Bench — UAPA and NDPS bail: https://www.barandbench.com/columns/when-arrest-becomes-the-burden-what-parliaments-uapa-data-really-tells-us
- PRS
— Police reforms: https://prsindia.org/policy/analytical-reports/police-reforms-india
- NCB
— Official: https://www.narcoticsindia.nic.in
